Related Experiment Video
Updated: Sep 14, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
An approach for cancer outcomes modelling using a comprehensive synthetic dataset
Lorna Tu1,2, Hervé H F Choi3,4, Haley Clark5,4,6
1Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada. lornatu@phas.ubc.ca.
Generating synthetic patient data with prognostic information can aid cancer outcome prediction. This approach mimics real data, enabling robust machine learning model development for improved survival analysis.
Area of Science:
- Medical informatics
- Machine learning in oncology
- Radiomics and clinical data integration
Background:
- Limited patient data hinders machine learning (ML) model development for cancer outcome prediction.
- Existing synthetic image generation methods often lack crucial prognostic information.
Purpose of the Study:
- To develop a cancer outcome modeling approach using a comprehensive synthetic dataset that accurately mimics real patient data.
- To evaluate the performance of ML models trained on synthetic data for predicting patient survival.
Main Methods:
- A real dataset of 132 non-small cell lung cancer patients (CT-based radiomic and clinical features) was utilized.
- A synthetic dataset was generated using a conditional tabular generative adversarial network.
- Models predicting two-year overall survival were trained using various feature selection methods and ML algorithms, then tested on real data.
Main Results:
- Real and synthetic datasets showed high similarity (average 1-minus-KS statistic of 0.871 for continuous features; p<0.001 for discrete features).
- XGBoost with random forest importance features demonstrated consistent performance across both datasets (<1.3% difference in balanced accuracy and AUC-PR).
Conclusions:
- Synthetic radiomic and clinical data augmentation shows potential for cancer outcome modeling.
- Further validation with larger, diverse datasets is essential for broader application beyond lung cancer.
Related Concept Videos
Cancer Survival Analysis
Kaplan-Meier Approach
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Comparing the Survival Analysis of Two or More Groups

